Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)
Metamizole: inconsistent information regarding dosage and contraindications
2019.04.04
Active substance: Metamizol
04.04.2019 - Realisation of the EU Commission's implementing decision
The Federal Institute for Drugs and Medical Devices (BfArM) is implementing the corresponding implementation decision of the European Commission of 20 March 2019 in its decision of 28 March 2019.
14.12.2018 - CHMP opinion
The EMA recommends harmonizing the dosage of metamizole-containing drugs and their use during pregnancy and breastfeeding.
04.06.2018 - Procedure started
The European Medicines Agency (EMA) has started a review of medicines containing metamizole.
Further information
For details regarding the procedure please click on the following link to the European Medicines Agency (EMA):